392 related articles for article (PubMed ID: 31584460)
1. Fibrosis Mediators in the Colonic Mucosa of Acute and Healed Ulcerative Colitis.
Gundersen MD; Goll R; Fenton CG; Anderssen E; Sørbye SW; Florholmen JR; Paulssen RH
Clin Transl Gastroenterol; 2019 Oct; 10(10):e00082. PubMed ID: 31584460
[TBL] [Abstract][Full Text] [Related]
2. Normalization of mucosal tumor necrosis factor-α: A new criterion for discontinuing infliximab therapy in ulcerative colitis.
Olsen T; Rismo R; Gundersen MD; Paulssen EJ; Johnsen K; Kvamme JM; Goll R; Florholmen J
Cytokine; 2016 Mar; 79():90-5. PubMed ID: 26775117
[TBL] [Abstract][Full Text] [Related]
3. Effect of vedolizumab (anti-α4β7-integrin) therapy on histological healing and mucosal gene expression in patients with UC.
Arijs I; De Hertogh G; Lemmens B; Van Lommel L; de Bruyn M; Vanhove W; Cleynen I; Machiels K; Ferrante M; Schuit F; Van Assche G; Rutgeerts P; Vermeire S
Gut; 2018 Jan; 67(1):43-52. PubMed ID: 27802155
[TBL] [Abstract][Full Text] [Related]
4. Infliximab therapy downregulation of basic fibroblast growth factor/syndecan 1 link: a possible molecular pathway of mucosal healing in ulcerative colitis.
Ierardi E; Giorgio F; Zotti M; Rosania R; Principi M; Marangi S; Della Valle N; De Francesco V; Di Leo A; Ingrosso M; Panella C
J Clin Pathol; 2011 Nov; 64(11):968-72. PubMed ID: 21945924
[TBL] [Abstract][Full Text] [Related]
5. Novel oral-targeted therapies for mucosal healing in ulcerative colitis.
Antonelli E; Villanacci V; Bassotti G
World J Gastroenterol; 2018 Dec; 24(47):5322-5330. PubMed ID: 30598577
[TBL] [Abstract][Full Text] [Related]
6. Mucosal gene transcription of ulcerative colitis in endoscopic remission.
Arkteg CB; Goll R; Gundersen MD; Anderssen E; Fenton C; Florholmen J
Scand J Gastroenterol; 2020 Feb; 55(2):139-147. PubMed ID: 31918598
[No Abstract] [Full Text] [Related]
7. Ultrastructural evidence of mucosal healing after infliximab in patients with ulcerative colitis.
Fratila OC; Craciun C
J Gastrointestin Liver Dis; 2010 Jun; 19(2):147-53. PubMed ID: 20593047
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Infliximab Biosimilar CT-P13 Induction Therapy on Mucosal Healing in Ulcerative Colitis.
Farkas K; Rutka M; Golovics PA; Végh Z; Lovász BD; Nyári T; Gecse KB; Kolar M; Bortlik M; Duricova D; Machkova N; Hruba V; Lukas M; Mitrova K; Malickova K; Bálint A; Nagy F; Bor R; Milassin Á; Szepes Z; Palatka K; Lakatos PL; Lukas M; Molnár T
J Crohns Colitis; 2016 Nov; 10(11):1273-1278. PubMed ID: 27106537
[TBL] [Abstract][Full Text] [Related]
9. Histological healing after infliximab induction therapy in children with ulcerative colitis.
Wiernicka A; Szymanska S; Cielecka-Kuszyk J; Dadalski M; Kierkus J
World J Gastroenterol; 2015 Oct; 21(37):10654-61. PubMed ID: 26457025
[TBL] [Abstract][Full Text] [Related]
10. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.
Matsuda R; Koide T; Tokoro C; Yamamoto T; Godai T; Morohashi T; Fujita Y; Takahashi D; Kawana I; Suzuki S; Umemura S
Inflamm Bowel Dis; 2009 Mar; 15(3):328-34. PubMed ID: 18942752
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study.
Barreiro-de Acosta M; Vallejo N; de la Iglesia D; Uribarri L; Bastón I; Ferreiro-Iglesias R; Lorenzo A; Domínguez-Muñoz JE
J Crohns Colitis; 2016 Jan; 10(1):13-9. PubMed ID: 26351390
[TBL] [Abstract][Full Text] [Related]
12. Vedolizumab Induces Long-term Mucosal Healing in Patients With Crohn's Disease and Ulcerative Colitis.
Noman M; Ferrante M; Bisschops R; De Hertogh G; Van den Broeck K; Rans K; Rutgeerts P; Vermeire S; Van Assche G
J Crohns Colitis; 2017 Sep; 11(9):1085-1089. PubMed ID: 28369329
[TBL] [Abstract][Full Text] [Related]
13. Direct effect of infliximab on intestinal mucosa sustains mucosal healing: exploring new mechanisms of action.
Petito V; Lopetuso LR; Arena V; Stigliano E; Boninsegna A; Bibbò S; Poscia A; Alfieri S; Rosa F; Amato A; Cammarota G; Papa A; Sgambato A; Gasbarrini A; Scaldaferri F
Dig Liver Dis; 2016 Apr; 48(4):391-8. PubMed ID: 26804809
[TBL] [Abstract][Full Text] [Related]
14. Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes.
Christensen B; Hanauer SB; Erlich J; Kassim O; Gibson PR; Turner JR; Hart J; Rubin DT
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1557-1564.e1. PubMed ID: 28238954
[TBL] [Abstract][Full Text] [Related]
15. Confocal laser endomicroscopy in ulcerative colitis: beyond endoscopic assessment of disease activity.
Maione F; Giglio MC; Luglio G; Rispo A; D'Armiento M; Manzo B; Cassese G; Schettino P; Gennarelli N; Siciliano S; D'Armiento FP; De Palma GD
Tech Coloproctol; 2017 Jul; 21(7):531-540. PubMed ID: 28674950
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of mucosal healing of ulcerative colitis by a quantitative fecal immunochemical test.
Nakarai A; Kato J; Hiraoka S; Kuriyama M; Akita M; Hirakawa T; Okada H; Yamamoto K
Am J Gastroenterol; 2013 Jan; 108(1):83-9. PubMed ID: 23007005
[TBL] [Abstract][Full Text] [Related]
17. Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients.
Chaparro M; Barreiro-de Acosta M; Echarri A; Almendros R; Barrio J; Llao J; Gomollón F; Vera M; Cabriada JL; Guardiola J; Guerra I; Beltrán B; Roncero O; Busquets D; Taxonera C; Calvet X; Ferreiro-Iglesias R; Ollero Pena V; Bernardo D; Donday MG; Garre A; Godino A; Díaz A; Gisbert JP
Dig Dis Sci; 2019 Mar; 64(3):846-854. PubMed ID: 30426297
[TBL] [Abstract][Full Text] [Related]
18. Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis.
Tew GW; Hackney JA; Gibbons D; Lamb CA; Luca D; Egen JG; Diehl L; Eastham Anderson J; Vermeire S; Mansfield JC; Feagan BG; Panes J; Baumgart DC; Schreiber S; Dotan I; Sandborn WJ; Kirby JA; Irving PM; De Hertogh G; Van Assche GA; Rutgeerts P; O'Byrne S; Hayday A; Keir ME
Gastroenterology; 2016 Feb; 150(2):477-87.e9. PubMed ID: 26522261
[TBL] [Abstract][Full Text] [Related]
19. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
Colombel JF; Rutgeerts P; Reinisch W; Esser D; Wang Y; Lang Y; Marano CW; Strauss R; Oddens BJ; Feagan BG; Hanauer SB; Lichtenstein GR; Present D; Sands BE; Sandborn WJ
Gastroenterology; 2011 Oct; 141(4):1194-201. PubMed ID: 21723220
[TBL] [Abstract][Full Text] [Related]
20. Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-Label Trial of Patients With Ulcerative Colitis.
Telesco SE; Brodmerkel C; Zhang H; Kim LL; Johanns J; Mazumder A; Li K; Baribaud F; Curran M; Strauss R; Paxson B; Plevy S; Davison T; Knight L; Dibben S; Schreiber S; Sandborn W; Rutgeerts P; Siegel CA; Reinisch W; Greenbaum LE
Gastroenterology; 2018 Oct; 155(4):1008-1011.e8. PubMed ID: 29981298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
